Skip to content
Business Company News, Medical Health Aged Care

HeraMED Limited (ASX:HMD) ANNOUNCES SOFT LAUNCH OF HERACARE BY TELSTRA HEALTH UNDERWAY

Jane Morgan Management 3 mins read

Highlights:

  • HeraCARE will soon be available to medical practices using Telstra Health’s MedicalDirector patient management software.

  • HeraMED initially announced its partnership with Telstra Health’s MedicalDirector platform in November 2023. HeraCARE is the first remote maternity solution to join the Telstra Health digital ecosystem.

  • A soft launch was recently announced by Telstra Health at the Royal Australian College of General Practitioners (RACGP) Practice Owners Conference in Cairns, Australia.

  • The initial step in the commercial rollout focuses on recruiting 5-10 GP clinics as 'early adopters' for integrating HeraCARE into MedicalDirector, optimizing care models and commercial models.

  • On completion of the soft launch, HeraMED targets onboarding mums through Telstra Health’s extensive GP customer base by the end of calendar year 2024.

  • HeraCARE will be available within Telstra Health’s Smart Connected Care ecosystem, integrating into Telstra Health’s core platforms.

  • This partnership supports HeraMED’s commercialisation strategy targeting the GP vertical, enhancing prenatal and postpartum maternity care experiences.

SYDNEY AUSTRALIA,– June 24, 2024 – HeraMED Limited (ASX) a leader in the digital transformation of maternity care, today announced the soft launch of HeraCARE within the Telstra Health ecosystem through targeted GP clinics.

In November 2023, HeraMED announced its partnership with Telstra Health’s MedicalDirector platform servicing GP and healthcare professionals, marking HeraCARE as the first remote maternity solution to join the Telstra Health digital ecosystem. The soft launch of HeraCARE into Telstra Health’s Smart Connected Care was recently announced at the RACGP Practice Owners Conference in Cairns, Australia.

The initial step in the commercial rollout focuses on recruiting the first group of GP clinics ('early adopters') for integrating HeraCARE into MedicalDirector and GP workflows. This phase aims to optimize care and commercial models while gathering feedback from the Beta Program before a full launch to the larger network. On completion of the soft launch, HeraMED anticipates marketing to the entire GP clinic customer base and onboarding mums through Telstra Health’s GP clinics by the end of calendar year 2024.

HeraMED and Telstra Health will jointly promote the integration of HeraCARE into the Smart Connected Care ecosystem through education and marketing initiatives as part of the Smart Partner Marketing Plan.

CEO of HeraMED, Anoushka Gungadin, stated, "HeraCARE is a mum-centric solution and the partnership with Telstra Health allows us to expand access to care for many more mums, given the significant role GPs play in maternity, pregnancy and postpartum care. Following integration and commercial rollout within this new ecosystem, we are targeting the onboarding of mums through GP practices by the end of calendar year 2024. This aligns with the four-point plan both for commercialisation and strategic partnership while redefining how maternity care is delivered and experienced."

About Telstra Health: At Telstra Health, we work to improve lives through digitally-enabled care for our community.

Our vision drives us as we strive to realise a connected and improved digital health experience for all. We have established a unique footprint, both locally in Australia and internationally, and we have deep experience and expertise across the entire spectrum of health, aged care and social services.

We work with care providers in the hospital, health service, general practice, pharmacy, and aged care sectors to connect health information, clinicians and consumers. We also partner with industry-leading specialist organisations to successfully deliver critical national services.

Our clinical and administrative systems, population health solutions, and information exchange platforms help providers and government organisations to improve the quality, safety and efficiency of the healthcare they deliver. We also help enable clinicians to deliver care in new ways through our virtual care and consumer solutions. We support healthcare organisations to make better informed decisions through our advisory services and end-to-end analytics and artificial intelligence solutions.

Collectively, our digital health solutions help to solve some of the biggest challenges facing the health and aged care sectors and represent an important element in delivering outcomes that matter to patients and clinicians.

 


About us:

About HeraMED Limited (ASX): HeraMED is an innovative medical data and technology company leading the digital transformation of maternity care by revolutionising the prenatal and postpartum experience with its hybrid maternity care platform. HeraMED offers a proprietary platform that utilises hardware and software to reshape the Doctor/Patient relationship using its clinically validated in-home foetal and maternal heart rate monitor, HeraBEAT, cloud computing, artificial intelligence, and big data.

The Company’s proprietary offering, HeraCARE, has been engineered to offer a fully integrated maternal health ecosystem designed to deliver better care at a lower cost, ensure expectant mothers are engaged, informed and well-supported, allow healthcare professionals to provide the highest quality care and enable early detection and prevention of potential risks.

 


Contact details:

Investor & Media Relations
Jane Morgan
M: +61 405 555 618
E: [email protected]

Media

More from this category

  • Business Company News, Finance Investment
  • 16/12/2025
  • 14:53
Emanda

Emanda’s new investors back a smarter way to value a business

Key Facts: Emanda has secured AUD $300k in pre-seed funding from M8 Ventures, Torus Ventures, Melbourne Angels and angel investors to develop its business…

  • Contains:
  • Medical Health Aged Care
  • 16/12/2025
  • 12:11
Esco Aster Pte. Ltd.

Esco Aster Signs Exosome Clinical cGMP Manufacturing Contract With Shine-On Biomedical For A Novel First-In-Class HLA-G Targeting Exosome Drug Delivery Platform

SINGAPORE–BUSINESS WIRE– Esco Aster, a vertically integrated cell and derivatives CRDMO based at JTC LaunchPad Singapore, announced CMC manufacturing support for Shine-On Biomedical’s HLA-G…

  • Contains:
  • Medical Health Aged Care
  • 16/12/2025
  • 11:30
Dementia Australia

Dementia Australia pays tribute to Patron Allan Moffat OBE

Dementia Australia solemnly acknowledges the Victorian State Memorial Service to honour and celebrate Allan Moffat OBE to be held today at Melbourne Town Hall. Mr Moffat, the Motorsport racing legend died from Alzheimer’s disease on 22 November and was a Patron of Dementia Australia following his decision to speak out publicly about his diagnosis to help raise funds and awareness of dementia. Dementia Australia acknowledges the condolences and support from The Hon. Jacinta Allan MP, Premier of Victoria, the Victorian State Government and Australian Federal Government in remembering Allan’s extraordinary career and dementia advocacy. Dementia Australia extends thanks to the…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.